Cargando…

Inflammatory and Prothrombotic Biomarkers, DNA Polymorphisms, MicroRNAs and Personalized Medicine for Patients with Peripheral Arterial Disease

Classical risk factors play a major role in the initiation and development of atherosclerosis. However, the estimation of risk for cardiovascular events based only on risk factors is often insufficient. Efforts have been made to identify biomarkers that indicate ongoing atherosclerosis. Among import...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poredoš, Pavel, Šabovič, Mišo, Božič Mijovski, Mojca, Nikolajević, Jovana, Antignani, Pier Luigi, Paraskevas, Kosmas I., Mikhailidis, Dimitri P., Blinc, Aleš
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569699/ https://www.ncbi.nlm.nih.gov/pubmed/36233355 http://dx.doi.org/10.3390/ijms231912054

Ejemplares similares

Inflammatory, Metabolic, and Coagulation Effects on Medial Arterial Calcification in Patients with Peripheral Arterial Disease
por: Nikolajević, Jovana, et al.
Publicado: (2023)

The Role of MicroRNAs in Endothelial Cell Senescence
por: Nikolajevic, Jovana, et al.
Publicado: (2022)

Molecular Mechanisms Responsible for Diastolic Dysfunction in Diabetes Mellitus Patients
por: Nikolajević Starčević, Jovana, et al.
Publicado: (2019)

Nonischemic ST segment elevation in hypertrophic cardiomyopathy due to chest wall deformity from kyphoscoliosis
por: Blinc, Aleš, et al.
Publicado: (2010)

Prognostic Factors for Restenosis of Superficial Femoral Artery after Endovascular Treatment
por: Boc, Vinko, et al.
Publicado: (2023)

Increased Plasma Cathepsin s at the Time of Percutaneous Transluminal Angioplasty is Associated with 6-months’ Restenosis of the Femoropopliteal Artery
por: Mijovski, Mojca Bozic, et al.
Publicado: (2018)

Time Course of Inflammatory and Procoagulant Markers in the Early Period After Total Hip Replacement
por: Poredos, Peter, et al.
Publicado: (2021)

Patients with an Inflamed Atherosclerotic Plaque have Increased Levels of Circulating Inflammatory Markers
por: Poredos, Pavel, et al.
Publicado: (2017)

Arterial Stiffness and Cardiovascular Therapy
por: Janić, Miodrag, et al.
Publicado: (2014)

A Low-Dose Combination of Fluvastatin and Valsartan: A New “Drug” and a New Approach for Decreasing the Arterial Age
por: Janić, Miodrag, et al.
Publicado: (2015)

Treating Arterial Ageing in Patients with Diabetes: From Mechanisms to Effective Drugs
por: Lunder, Mojca, et al.
Publicado: (2021)

18F-Fluorodeoxyglucose Uptake in Abdominal Aortic Aneurysms: A Useful Biomarker of AAA Rupture Risk
por: Paraskevas, Kosmas I., et al.
Publicado: (2014)

Associations among different functional and structural arterial wall properties and their relations to traditional cardiovascular risk factors in healthy subjects: a cross-sectional study
por: Lunder, Mojca, et al.
Publicado: (2012)

Association between Lipoprotein Subfractions, Hemostatic Potentials, and Coronary Atherosclerosis
por: Poropat Flerin, Tadeja, et al.
Publicado: (2022)

The Correlation between the Triglyceride-Glucose Index and Coagulation Markers in Patients with Recent Acute Myocardial Infarction
por: Košuta, Daniel, et al.
Publicado: (2022)

Empagliflozin-Metformin Combination Has Antioxidative and Anti-Inflammatory Properties that Correlate with Vascular Protection in Adults with Type 1 Diabetes
por: Janić, Miodrag, et al.
Publicado: (2022)

The Impact of Lower Extremity Venous Ulcers due to Chronic Venous Insufficiency on Quality of Life
por: Koupidis, Sotirios A, et al.
Publicado: (2008)

The preventive cardiovascular effect of a combination of statin and angiotensin receptor blocker at sub-therapeutic doses in middle-aged healthy volunteers
por: Šinigoj, Petra, et al.
Publicado: (2009)

A low-dose atorvastatin and losartan combination directly improves aortic ring relaxation and diminishes ischaemic-reperfusion injury in isolated rat hearts
por: Lunder, Mojca, et al.
Publicado: (2012)

Coenzyme Q10 Supplementation Decreases Statin-Related Mild-to-Moderate Muscle Symptoms: A Randomized Clinical Study
por: Skarlovnik, Ajda, et al.
Publicado: (2014)

Expression of Longevity Genes Induced by a Low-Dose Fluvastatin and Valsartan Combination with the Potential to Prevent/Treat “Aging-Related Disorders”
por: Janić, Miodrag, et al.
Publicado: (2019)

Endocan Is an Independent Predictor of Heart Failure-Related Mortality and Hospitalizations in Patients with Chronic Stable Heart Failure
por: Kosir, Gorazd, et al.
Publicado: (2019)

Biocompatibility Parameters with Standard and Increased Dose of Citrate in Hemodialysis—A Randomized Trial
por: Orsag, Alesa, et al.
Publicado: (2021)

Biological Variation in Rotational Thromboelastometry in Patients with Atrial Fibrillation Receiving Rivaroxaban
por: Božič Mijovski, Mojca, et al.
Publicado: (2022)

Insulin resistance, lipids and body composition in patients with coronary artery disease after combined aerobic training and resistance training: a randomised, controlled trial
por: Kambic, Tim, et al.
Publicado: (2023)

Increased Fluorodeoxyglucose Uptake Following Endovascular Abdominal Aortic Aneurysm Repair: A Predictor of Endoleak?
por: Paraskevas, Kosmas I, et al.
Publicado: (2010)

Revascularization of Peripheral Arteries in Patients with Intermittent Claudication Decreases Inflammatory Biomarkers
por: Poredoš, Pavel, et al.
Publicado: (2023)

Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus
por: Lunder, Mojca, et al.
Publicado: (2018)

Short-Term Water- and Land-Based Exercise Training Comparably Improve Exercise Capacity and Vascular Function in Patients After a Recent Coronary Event: A Pilot Randomized Controlled Trial
por: Vasić, Danijela, et al.
Publicado: (2019)

Lipoprotein(a) and inflammation in patients with atrial fibrillation after electrical cardioversion
por: Naji, Franjo, et al.
Publicado: (2011)

Refractory drug-induced systemic small-vessel vasculitis with two varied extracutaneous manifestations: a case report and review of the literature
por: Jovanovic, Mark, et al.
Publicado: (2023)

The in vitro addition of idarucizumab to plasma samples from patients increases thrombin generation
por: Božič Mijovski, Mojca, et al.
Publicado: (2021)

Comparison of antithrombin activity assays in detection of patients with heparin binding site antithrombin deficiency: systematic review and meta-analysis
por: Rojnik, Tamara, et al.
Publicado: (2023)

Assessment of short-term effect of platelet-rich plasma treatment of tendinosis using texture analysis of ultrasound images
por: Pintaric, Karlo, et al.
Publicado: (2023)

Cholesterol, carotid artery disease and stroke: what the vascular specialist needs to know
por: Paraskevas, Kosmas I., et al.
Publicado: (2020)

Proinflammatory and Prothrombotic Effects of Hypoglycemia
por: Dandona, Paresh, et al.
Publicado: (2010)

Polymorphisms of the PPAR-γ (rs1801282) and Its Coactivator (rs8192673) Have a Minor Effect on Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus
por: Pleskovič, Aleš, et al.
Publicado: (2016)

Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide Anti-Atherosclerotic Mechanisms of Action Study (SAMAS)
por: Janić, Miodrag, et al.
Publicado: (2022)

HFpEF and Atrial Fibrillation: The Enigmatic Interplay of Dysmetabolism, Biomarkers, and Vascular Endothelial Dysfunction
por: Bosanac, Jure, et al.
Publicado: (2022)

Stable phase post-MI patients have elevated VEGF levels correlated with inflammation markers, but not with atherosclerotic burden
por: Eržen, Barbara, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_cma9kghbtrc2m3hhe2sh0n1q0s